Peer-reviewedCC BY 4.0iScience
Oncogenic CLDN1 promotes thyroid cancer progression through TAp63-mediated glycolytic switching
Related
- FAM50A promotes esophageal squamous cell carcinoma progression via splicing-dependent oncogenic circSDK1- and DUSP22-mediated MAPK/FAK activation.
- Oncogenic hsa_circ_0000247 Promotes Breast Cancer Malignancy Through hsa‐let‐7i‐5p Sponging‐Mediated HMGA1 Upregulation
- N-WASP deficiency enhances oncogenic KRAS-mediated lung adenocarcinoma progression in mice
- RBM15/IGF2BP1-mediated m 6A methylation of AKR1B10 promotes the progression of cervical squamous cell carcinoma
- BCAM-AKT2 fusion protein promotes unfolded protein response driven oncogenic signaling in SKOV3 epithelial ovarian cancer cell line
BibTeX
@article{zhang2026oncogenic,
title = {{Oncogenic CLDN1 promotes thyroid cancer progression through TAp63-mediated glycolytic switching}},
author = {Bowei Zhang and Jinju Wang and Qianxi Zhang and Quanxin Wan},
journal = {iScience},
year = {2026},
month = nov,
doi = {10.1016/j.isci.2026.117943},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2589004226033262},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Oncogenic CLDN1 promotes thyroid cancer progression through TAp63-mediated glycolytic switching
AU - Bowei Zhang
AU - Jinju Wang
AU - Qianxi Zhang
AU - Quanxin Wan
PY - 2026
DA - 2026/11/01
JO - iScience
DO - 10.1016/j.isci.2026.117943
UR - https://linkinghub.elsevier.com/retrieve/pii/S2589004226033262
SN - 2589-0042
ER -